BioMarin to Present at the JMP Securities Research Conference - Earthtimes (press release)

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service52 times read : Adjust font size: Decrease font Enlarge font
image

... with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany ; and Firdapse? (amifampridine phosphate), which has ...

Read this article...



Post your comment comment Comments (0 posted)

copyright